EGFR-targeted immunoliposomes as a selective delivery system of simvastatin, with potential use in treatment of triple-negative breast cancers-Reference-Cited by-同舟云学术

EGFR-targeted immunoliposomes as a selective delivery system of simvastatin, with potential use in treatment of triple-negative breast cancers

Published:2019-10 Issue: Volume:569 Page:118605
ISSN:0378-5173
Container-title:International Journal of Pharmaceutics
language:en
Short-container-title:International Journal of Pharmaceutics

Author:

Matusewicz Lucyna,Filip-Psurska Beata,Psurski Mateusz,Tabaczar Sabina,Podkalicka Joanna,Wietrzyk Joanna,Ziółkowski Piotr,Czogalla Aleksander^ORCID,Sikorski Aleksander F.^ORCID

Funder

National Science Center

The Polpharma Scientific Foundation

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference53 articles.

1. Statins and breast cancer prognosis: evidence and opportunities;Ahern;Lancet Oncol.,2014

2. Effect of the magnitude of lipid lowering on risk of elevated liver enzymes, rhabdomyolysis, and cancer: insights from large randomized statin trials;Alsheikh-Ali;J. Am. Coll. Cardiol.,2007

3. Liposomal simvastatin inhibits tumor growth via targeting tumor-associated macrophages-mediated oxidative stress;Alupei;Cancer Lett.,2015

4. Unfavorable effect of calcitriol and its low-calcemic analogs on metastasis of 4T1 mouse mammary gland cancer;Anisiewicz;Int. J. Oncol.,2018

5. Validated spectrophotometric method for quantitative determination of simvastatin in pharmaceutical formulations and human serum;Arayne;J. Anal. Chem.,2007

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Microfluidic-enabled aptamer-modified liposomal probes for targeted transient triplet differential photoacoustic imaging;Sensors and Actuators B: Chemical;2024-12

2. Targeted Cancer Therapy‐on‐A‐Chip;Advanced Healthcare Materials;2024-08-05

3. Repurposing simvastatin in cancer treatment: an updated review on pharmacological and nanotechnological aspects;Naunyn-Schmiedeberg's Archives of Pharmacology;2024-05-15

4. Review of recent preclinical and clinical research on ligand-targeted liposomes as delivery systems in triple negative breast cancer therapy;Journal of Liposome Research;2024-03-23

5. Targeted internalization and activation of glycosidic switch liposomes by an EphA2 PEG engager increases therapeutic efficacy against lung cancer;2024-02-23